首页 > 最新文献

Indian journal of cancer最新文献

英文 中文
Eyelid myeloid sarcoma heralding relapse of acute myeloid leukemia in a child: First report from India and literature review. 儿童眼睑髓性肉瘤预示急性髓性白血病复发:来自印度的首次报道和文献综述。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_980_21
Ankur Jain, Pooja Prasad, Sumita Chaudhry, D K Gupta, Sumita Saluja

Abstract: Myeloid sarcoma (MS) refers to an extramedullary collection of immature cells of granulocytic series and occurs either in isolation or in association with myeloid malignancies, particularly acute myeloid leukemia (AML). We report a 16-year old girl with AML who was treated at our hospital with standard "7 + 3" induction chemotherapy and achieved morphological remission. She developed a small nodule below her right eyelid at day 10 of first consolidation chemotherapy with high-dose cytarabine. Eyelid lesion increased in size despite oral antibiotics. Peripheral blood did not show any blasts. However, bone marrow examination was consistent with relapsed AML. She was treated with salvage chemotherapy followed by allogeneic stem cell transplant. However, her disease relapsed 2 months later and she died. This is the first case of eyelid MS from India in which eyelid MS developed during chemotherapy for AML and heralded the subsequent disease relapse. Eyelid MS could be a sinister manifestation of AML. Literature regarding eyelid MS is discussed in brief.

髓系肉瘤(Myeloid sarcoma, MS)是一种髓外粒细胞系未成熟细胞的集合,可单独发生或与髓系恶性肿瘤,特别是急性髓系白血病(AML)相关。我们报告了一位16岁的AML女孩,她在我院接受了标准的“7 + 3”诱导化疗,并获得了形态缓解。患者于第一次大剂量阿糖胞苷巩固化疗第10天右眼睑下出现小结节。尽管口服抗生素,眼睑病变仍增大。外周血未见任何原细胞。然而,骨髓检查与复发性AML一致。她接受了补救性化疗,随后进行了异体干细胞移植。然而,她的疾病在2个月后复发并死亡。这是来自印度的第一例眼睑MS病例,其中眼睑MS在AML化疗期间发展并预示着随后的疾病复发。眼睑MS可能是AML的险恶表现。本文对眼睑多发性硬化症的相关文献进行了简要的讨论。
{"title":"Eyelid myeloid sarcoma heralding relapse of acute myeloid leukemia in a child: First report from India and literature review.","authors":"Ankur Jain, Pooja Prasad, Sumita Chaudhry, D K Gupta, Sumita Saluja","doi":"10.4103/ijc.ijc_980_21","DOIUrl":"10.4103/ijc.ijc_980_21","url":null,"abstract":"<p><strong>Abstract: </strong>Myeloid sarcoma (MS) refers to an extramedullary collection of immature cells of granulocytic series and occurs either in isolation or in association with myeloid malignancies, particularly acute myeloid leukemia (AML). We report a 16-year old girl with AML who was treated at our hospital with standard \"7 + 3\" induction chemotherapy and achieved morphological remission. She developed a small nodule below her right eyelid at day 10 of first consolidation chemotherapy with high-dose cytarabine. Eyelid lesion increased in size despite oral antibiotics. Peripheral blood did not show any blasts. However, bone marrow examination was consistent with relapsed AML. She was treated with salvage chemotherapy followed by allogeneic stem cell transplant. However, her disease relapsed 2 months later and she died. This is the first case of eyelid MS from India in which eyelid MS developed during chemotherapy for AML and heralded the subsequent disease relapse. Eyelid MS could be a sinister manifestation of AML. Literature regarding eyelid MS is discussed in brief.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"432-435"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monoclonal antibodies in 2025: From milestones to new frontiers. 2025年的单克隆抗体:从里程碑到新领域。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_9_25
Avinash Deo
{"title":"Monoclonal antibodies in 2025: From milestones to new frontiers.","authors":"Avinash Deo","doi":"10.4103/ijc.ijc_9_25","DOIUrl":"https://doi.org/10.4103/ijc.ijc_9_25","url":null,"abstract":"","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"329-331"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The usefulness of 3D CT reconstruction in surgical planning for glomus tympanicum. 三维CT重建在鼓室球手术计划中的应用。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_1344_21
Carlo Pane-Pianese, Roberto Corona-Cedillo, Nathaly Rivera-Sotelo, Ernesto Roldan-Valadez

Abstract: Glomus tympanicum is a hypervascular, benign neoplasm with a slow rate of growth. The incidence of this pathology is higher in females than in males and mainly occurs in the fifth to sixth decade of life. Pulsatile tinnitus and hearing loss are the main clinical features. We present the case of a 70-year-old female patient who was admitted to the otolaryngology service with a 1-month history of epistaxis and equilibrium disorder that caused a ground-level fall.

摘要:鼓膜囊瘤是一种生长缓慢、血管增生的良性肿瘤。这种病理在女性中的发病率高于男性,主要发生在生命的第五至第六十年。搏动性耳鸣和听力损失是其主要临床特征。我们报告一位70岁的女性患者,因1个月的鼻出血和平衡障碍导致地面跌倒而入院。
{"title":"The usefulness of 3D CT reconstruction in surgical planning for glomus tympanicum.","authors":"Carlo Pane-Pianese, Roberto Corona-Cedillo, Nathaly Rivera-Sotelo, Ernesto Roldan-Valadez","doi":"10.4103/ijc.ijc_1344_21","DOIUrl":"https://doi.org/10.4103/ijc.ijc_1344_21","url":null,"abstract":"<p><strong>Abstract: </strong>Glomus tympanicum is a hypervascular, benign neoplasm with a slow rate of growth. The incidence of this pathology is higher in females than in males and mainly occurs in the fifth to sixth decade of life. Pulsatile tinnitus and hearing loss are the main clinical features. We present the case of a 70-year-old female patient who was admitted to the otolaryngology service with a 1-month history of epistaxis and equilibrium disorder that caused a ground-level fall.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"449-450"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"The Emperor of all Maladies - A biography of cancer" by Siddhartha Mukherjee: An essential read for oncologists. 悉达多·慕克吉的《百病之王——癌症传记》:肿瘤学家的必读之作。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_45_24
Chris Antony, Santosh S Mane
{"title":"\"The Emperor of all Maladies - A biography of cancer\" by Siddhartha Mukherjee: An essential read for oncologists.","authors":"Chris Antony, Santosh S Mane","doi":"10.4103/ijc.ijc_45_24","DOIUrl":"https://doi.org/10.4103/ijc.ijc_45_24","url":null,"abstract":"","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"465-466"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Succinate dehydrogenase deficient GIST: Case series and review of literature from a tertiary care center in India. 琥珀酸脱氢酶缺乏GIST:病例系列和文献综述来自印度三级保健中心。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_500_24
Akhil P Santhosh, Sameer Rastogi, Shamim A Shamim, Rajni Yadav, Dikhra Khan

Background: Succinate dehydrogenase (SDH) deficient gastrointestinal stromal tumor (GIST) is the most common type of wild type GIST characterized by lack of mutations in proto-oncogene receptor tyrosine kinase (KIT) or platelet-derived growth factor receptor alpha (PDFGR alpha) pathways. It has a unique predilection for females and young adults, with a relatively indolent prognosis and varied treatment modalities. Data regarding SDH GIST from the Indian subcontinent is sparse.

Materials and methods: This is a retrospective study of patients with SDH deficient GIST, who presented to the GIST clinic in a tertiary care center in India from 2016-2022. 9 out of 120 GIST patients were SDH deficient. All patients were discussed in GIST tumor board and pathologies were re-reviewed by a dedicated GIST pathologist. Data was collected retrospectively from prospectively maintained database.

Results: There were nine patients with median age of 48 years (range 15-63), of which there were 5 males (n = 5, 55.5%). Eight patients (n = 8, 88.8%) had primary in stomach, one had duodenal GIST. In stomach, body was the most common location (n = 6,75%). 3 out of 9 patients (n = 3, 33.3%) had multifocal disease. 8 out of 9 (88.8%) had metastasis at presentation. Most common site of metastasis was liver (7 out of 8, 87.5%) Lymph node involvement was present in 4 out of 9 patients (44.4%). One patient had classical Carneys triad at presentation. 8 out of 9 (88.8%) had epithelioid morphology and 1 (11.1%) had mixed epithelioid-spindle picture. 5 out of 9 (55.5%) patients had germline SDH mutations. Out of nine patients, one was put on observation post surgery and therapy was given for eight patients (n = 8,88.8%). Response to imatinib was very poor, 3 out of 5 patients (60%) had response with sunitinib, three were started on regorafenib out of which one had partial response and one patient had partial response with temozolomide. Median overall survival was NR- not reached (95% CI 12.96-NR).

Conclusion: SDH deficient GIST is a unique subtype of gastrointestinal stromal tumor with distinct clinic-pathological features, diagnostic modalities, therapeutic strategies, and genetic implications as compared to C-kit/PDGFR-alpha mutated GIST.

背景:琥珀酸脱氢酶(SDH)缺陷型胃肠道间质瘤(GIST)是最常见的野生型胃肠道间质瘤,其特征是原癌基因受体酪氨酸激酶(KIT)或血小板衍生生长因子受体α (PDFGR α)途径缺乏突变。它有一个独特的偏好于女性和年轻的成年人,与一个相对惰性的预后和多种治疗方式。来自印度次大陆的SDH GIST数据很少。材料和方法:这是一项对2016-2022年在印度三级保健中心GIST诊所就诊的SDH缺乏GIST患者的回顾性研究。120例GIST患者中有9例SDH缺乏。所有患者均在GIST肿瘤委员会进行讨论,并由专门的GIST病理学家重新审查病理。数据从前瞻性维护的数据库中回顾性收集。结果:9例患者中位年龄48岁(15 ~ 63岁),其中男性5例(n = 5,占55.5%)。8例(n = 8, 88.8%)原发于胃,1例为十二指肠间质瘤。在胃中,身体是最常见的部位(n = 6,75%)。9例患者中有3例(n = 3, 33.3%)为多灶性疾病。9例患者中有8例(88.8%)出现转移。最常见的转移部位为肝脏(7 / 8,87.5%),9例患者中有4例(44.4%)出现淋巴结转移。一名患者在就诊时患有古典卡尼斯三联征。9例中有8例(88.8%)呈上皮样形态,1例(11.1%)呈上皮样-纺锤体混合形态。9例患者中有5例(55.5%)存在种系SDH突变。9例患者中术后观察1例,治疗8例(n = 8,88.8%)。对伊马替尼的反应非常差,5名患者中有3名(60%)对舒尼替尼有反应,3名开始使用瑞非尼,其中1名有部分反应,1名患者对替莫唑胺有部分反应。中位总生存期为NR-未达到(95% CI 12.96-NR)。结论:与C-kit/ pdgfr - α突变的GIST相比,SDH缺陷GIST是一种独特的胃肠道间质瘤亚型,具有不同的临床病理特征、诊断方式、治疗策略和遗传意义。
{"title":"Succinate dehydrogenase deficient GIST: Case series and review of literature from a tertiary care center in India.","authors":"Akhil P Santhosh, Sameer Rastogi, Shamim A Shamim, Rajni Yadav, Dikhra Khan","doi":"10.4103/ijc.ijc_500_24","DOIUrl":"10.4103/ijc.ijc_500_24","url":null,"abstract":"<p><strong>Background: </strong>Succinate dehydrogenase (SDH) deficient gastrointestinal stromal tumor (GIST) is the most common type of wild type GIST characterized by lack of mutations in proto-oncogene receptor tyrosine kinase (KIT) or platelet-derived growth factor receptor alpha (PDFGR alpha) pathways. It has a unique predilection for females and young adults, with a relatively indolent prognosis and varied treatment modalities. Data regarding SDH GIST from the Indian subcontinent is sparse.</p><p><strong>Materials and methods: </strong>This is a retrospective study of patients with SDH deficient GIST, who presented to the GIST clinic in a tertiary care center in India from 2016-2022. 9 out of 120 GIST patients were SDH deficient. All patients were discussed in GIST tumor board and pathologies were re-reviewed by a dedicated GIST pathologist. Data was collected retrospectively from prospectively maintained database.</p><p><strong>Results: </strong>There were nine patients with median age of 48 years (range 15-63), of which there were 5 males (n = 5, 55.5%). Eight patients (n = 8, 88.8%) had primary in stomach, one had duodenal GIST. In stomach, body was the most common location (n = 6,75%). 3 out of 9 patients (n = 3, 33.3%) had multifocal disease. 8 out of 9 (88.8%) had metastasis at presentation. Most common site of metastasis was liver (7 out of 8, 87.5%) Lymph node involvement was present in 4 out of 9 patients (44.4%). One patient had classical Carneys triad at presentation. 8 out of 9 (88.8%) had epithelioid morphology and 1 (11.1%) had mixed epithelioid-spindle picture. 5 out of 9 (55.5%) patients had germline SDH mutations. Out of nine patients, one was put on observation post surgery and therapy was given for eight patients (n = 8,88.8%). Response to imatinib was very poor, 3 out of 5 patients (60%) had response with sunitinib, three were started on regorafenib out of which one had partial response and one patient had partial response with temozolomide. Median overall survival was NR- not reached (95% CI 12.96-NR).</p><p><strong>Conclusion: </strong>SDH deficient GIST is a unique subtype of gastrointestinal stromal tumor with distinct clinic-pathological features, diagnostic modalities, therapeutic strategies, and genetic implications as compared to C-kit/PDGFR-alpha mutated GIST.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"408-415"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of educational intervention on knowledge of HPV and HPV vaccine and vaccine acceptability among teachers: A pilot investigation. 教育干预对教师HPV和HPV疫苗知识及疫苗接受程度的影响:一项试点调查。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_1032_23
Shivnath Ghosh, Pankhuri Bhatnagar, Rosy Chabbra

Background: Human papillomavirus (HPV) is a leading cause of cancer worldwide. In India, cancer of the cervix is ranked as the second and the first most frequent cancer for women in the state of Himachal Pradesh. The HPV vaccine has the potential to prevent cancers, but vaccine uptake has been low in India due to a lack of awareness, cultural acceptance, and non inclusion in the national immunization program. With the introduction of the indigenous vaccine, 'Cervavac', by the Government of India, a school based intervention can prove to be a cost effective and successful strategy in promoting the uptake of the HPV vaccine.

Methods: The current pilot study aimed to determine the impact of an educational intervention on HPV and HPV vaccine knowledge and the acceptability of the HPV vaccine among teachers who are parents of children aged 9 19 years in Shimla, a town in the North Western Himalayas. Twenty three teachers' participated in the pilot intervention. A paired 't' test was used to find out the difference in HPV and HPV vaccine knowledge and HPV vaccine acceptability in pre and post intervention conditions.

Results: The results revealed that there was a significant increase in knowledge of HPV (t = 6.97), knowledge of vaccine, and an increase in the acceptability in general (t = 2.78), HPV vaccination knowledge (t = 6.99), and HPV vaccine acceptability (t = 11.76) scores among the participants.

Conclusion: This study highlights the importance of HPV knowledge and awareness in improving vaccine acceptability, suggesting a tailored approach that engages the target population in vaccination decisions to augment uptake.

背景:人类乳头瘤病毒(HPV)是世界范围内癌症的主要原因。在印度喜马偕尔邦(Himachal Pradesh),子宫颈癌分别是女性最常见的第二和第一种癌症。人乳头瘤病毒疫苗具有预防癌症的潜力,但由于缺乏认识、文化接受和未纳入国家免疫规划,印度的疫苗接种率一直很低。随着印度政府引进本土疫苗“Cervavac”,以学校为基础的干预措施可以证明是促进人乳头瘤病毒疫苗接种的一种具有成本效益和成功的战略。方法:目前的试点研究旨在确定教育干预对HPV和HPV疫苗知识的影响,以及在喜马拉雅西北部西姆拉镇9 - 19岁儿童的父母中HPV疫苗的可接受性。23名教师参与了试点干预。采用配对t检验,了解干预前后患者对HPV和HPV疫苗的认知程度及HPV疫苗接受程度的差异。结果:调查结果显示,HPV知识(t = 6.97)、疫苗知识显著增加,总体可接受性(t = 2.78)、HPV疫苗接种知识(t = 6.99)和HPV疫苗可接受性(t = 11.76)得分显著增加。结论:本研究强调了HPV知识和意识在提高疫苗可接受性方面的重要性,建议采用一种量身定制的方法,使目标人群参与疫苗接种决策,以增加吸收率。
{"title":"Effect of educational intervention on knowledge of HPV and HPV vaccine and vaccine acceptability among teachers: A pilot investigation.","authors":"Shivnath Ghosh, Pankhuri Bhatnagar, Rosy Chabbra","doi":"10.4103/ijc.ijc_1032_23","DOIUrl":"https://doi.org/10.4103/ijc.ijc_1032_23","url":null,"abstract":"<p><strong>Background: </strong>Human papillomavirus (HPV) is a leading cause of cancer worldwide. In India, cancer of the cervix is ranked as the second and the first most frequent cancer for women in the state of Himachal Pradesh. The HPV vaccine has the potential to prevent cancers, but vaccine uptake has been low in India due to a lack of awareness, cultural acceptance, and non inclusion in the national immunization program. With the introduction of the indigenous vaccine, 'Cervavac', by the Government of India, a school based intervention can prove to be a cost effective and successful strategy in promoting the uptake of the HPV vaccine.</p><p><strong>Methods: </strong>The current pilot study aimed to determine the impact of an educational intervention on HPV and HPV vaccine knowledge and the acceptability of the HPV vaccine among teachers who are parents of children aged 9 19 years in Shimla, a town in the North Western Himalayas. Twenty three teachers' participated in the pilot intervention. A paired 't' test was used to find out the difference in HPV and HPV vaccine knowledge and HPV vaccine acceptability in pre and post intervention conditions.</p><p><strong>Results: </strong>The results revealed that there was a significant increase in knowledge of HPV (t = 6.97), knowledge of vaccine, and an increase in the acceptability in general (t = 2.78), HPV vaccination knowledge (t = 6.99), and HPV vaccine acceptability (t = 11.76) scores among the participants.</p><p><strong>Conclusion: </strong>This study highlights the importance of HPV knowledge and awareness in improving vaccine acceptability, suggesting a tailored approach that engages the target population in vaccination decisions to augment uptake.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"402-407"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation-induced lung injury due to extra thoracic irradiation. 胸部外照射引起的辐射致肺损伤。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_461_22
Shweta Anand, Dipti Gothi, Sunil Kumar, Mahismita Patro, Mayank Saxena

Background: To describe three cases of radiation-induced lung injury (RILI) occurring outside the radiation field and to review clinical, radiologic, and histologic aspects of RILI outside the radiation field.

Methods: We present case reports of three men with a mean age of 57.6 years, who had received radiation therapy and concomitant chemotherapy for supraglottic and laryngeal carcinoma. A detailed clinical, radiological, and laboratory evaluation was carried out to confirm the diagnosis.

Results: All our three patients developed radiation pneumonitis about 4 to 8 weeks after the completion of radiotherapy. All the three patients received radiation in the neck region. The lung infiltrates had developed outside the radiation field. Computed tomography of the chest showed ground glass opacity in the lower lung zones. One patient had grade 2 radiation pneumonitis, while the other two had grade 1. Two patients had grade 1 radiation pneumonitis spontaneously resolved, while one patient was advised inhaled steroids, though he was lost to follow-up.

Conclusions: RILI may occur away from the site of irradiation due to immunological and non-dosimetric factors. It is important to diagnose RILI at the earliest as management would vary with the grade of RILI. Grade 1 RILI may resolve spontaneously.

背景:描述三例发生在辐射场外的辐射性肺损伤(RILI),并回顾辐射场外的RILI的临床、放射学和组织学方面。方法:我们报告了3例平均年龄57.6岁的男性,他们接受了声门上癌和喉癌的放射治疗和化疗。进行了详细的临床、放射学和实验室评估以确认诊断。结果:3例患者均在放疗结束后4 ~ 8周发生放射性肺炎。三名患者均接受了颈部放疗。肺浸润已在辐射场外发展。胸部电脑断层显示肺下区磨玻璃影。1例患者为2级放射性肺炎,另外2例为1级。两名患者的1级放射性肺炎自行消退,而一名患者被建议吸入类固醇,尽管他没有随访。结论:由于免疫和非剂量学因素,RILI可能发生在远离照射部位的地方。早期诊断RILI是很重要的,因为治疗方法会随着RILI的等级而不同。1级RILI可自行消退。
{"title":"Radiation-induced lung injury due to extra thoracic irradiation.","authors":"Shweta Anand, Dipti Gothi, Sunil Kumar, Mahismita Patro, Mayank Saxena","doi":"10.4103/ijc.ijc_461_22","DOIUrl":"10.4103/ijc.ijc_461_22","url":null,"abstract":"<p><strong>Background: </strong>To describe three cases of radiation-induced lung injury (RILI) occurring outside the radiation field and to review clinical, radiologic, and histologic aspects of RILI outside the radiation field.</p><p><strong>Methods: </strong>We present case reports of three men with a mean age of 57.6 years, who had received radiation therapy and concomitant chemotherapy for supraglottic and laryngeal carcinoma. A detailed clinical, radiological, and laboratory evaluation was carried out to confirm the diagnosis.</p><p><strong>Results: </strong>All our three patients developed radiation pneumonitis about 4 to 8 weeks after the completion of radiotherapy. All the three patients received radiation in the neck region. The lung infiltrates had developed outside the radiation field. Computed tomography of the chest showed ground glass opacity in the lower lung zones. One patient had grade 2 radiation pneumonitis, while the other two had grade 1. Two patients had grade 1 radiation pneumonitis spontaneously resolved, while one patient was advised inhaled steroids, though he was lost to follow-up.</p><p><strong>Conclusions: </strong>RILI may occur away from the site of irradiation due to immunological and non-dosimetric factors. It is important to diagnose RILI at the earliest as management would vary with the grade of RILI. Grade 1 RILI may resolve spontaneously.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"332-336"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tobacco abuse among public transport bus employees in Mumbai, India: A randomized control trial. 印度孟买公共交通巴士员工吸烟:一项随机对照试验。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_1111_22
Vasundhara Y Kulkarni, Gauravi A Mishra, Sharmila A Pimple, Anil M Singal, Anil S Patil, Parishi V Majmudar, HeenaKauser A Shaikh

Background: Consumption of tobacco products including smokeless tobacco is a public health problem. Measures of tobacco control along with promotion of tobacco cessation will have a great impact in reducing the burden tobacco-related diseases. The objectives of current paper were to create cancer awareness and understand predictors influencing use of smokeless tobacco among the public transport bus employees.

Methods: Around 4000 public transport bus employees in Mumbai were enrolled after obtaining written informed consent. They were randomized in four arms. Pretest and posttest were conducted to assess their knowledge attitudes and practices regarding tobacco use. Employees were given detailed health education regarding hazards of tobacco and were invited for oral cancer screening. The screen positive participants were referred to the nodal hospital for further management.

Results: 2118 (52.95%) employees enrolled consumed tobacco in smokeless forms. Only 174 (8.21%) tobacco users used smoking forms. Khaini was the most common form of tobacco used, followed by masheri/gul. The median frequency of use of different tobacco products varied from 2 to 4 per day. The mean age at initiation of tobacco was 25.76 ± 8.46 years. According to the results of the multivariate analysis, married men, above 40 years, bus driver, belonging to Hindu religion, consuming alcohol, and with no family member using tobacco use were at higher risk of being chronic tobacco users.

Conclusion: Awareness about hazards of tobacco and stringent laws against use of smokeless tobacco should be implemented to guard the employees from harmful effects of tobacco use.

背景:包括无烟烟草在内的烟草制品消费是一个公共卫生问题。烟草控制措施以及促进戒烟将对减少与烟草有关的疾病负担产生重大影响。本论文的目的是提高对癌症的认识,并了解影响公共交通巴士员工使用无烟烟草的预测因素。方法:在获得书面知情同意后,对孟买约4000名公共交通巴士员工进行了调查。他们被随机分为四组。进行了前测和后测,以评估他们对烟草使用的知识、态度和做法。对员工进行了有关烟草危害的详细健康教育,并邀请他们进行口腔癌筛查。筛查阳性的参与者被转诊到淋巴结医院进行进一步治疗。结果:2118人(52.95%)使用无烟烟草。只有174名(8.21%)烟草使用者使用吸烟表格。Khaini是最常用的烟草形式,其次是masheri/gul。使用不同烟草制品的中位数频率从每天2次到4次不等。平均吸烟年龄为25.76±8.46岁。根据多变量分析的结果,已婚男性、40岁以上、公共汽车司机、信奉印度教、饮酒、没有家庭成员吸烟的人成为慢性烟草使用者的风险更高。结论:应提高对烟草危害的认识,严格禁止使用无烟烟草的法律,以保护员工免受烟草使用的有害影响。
{"title":"Tobacco abuse among public transport bus employees in Mumbai, India: A randomized control trial.","authors":"Vasundhara Y Kulkarni, Gauravi A Mishra, Sharmila A Pimple, Anil M Singal, Anil S Patil, Parishi V Majmudar, HeenaKauser A Shaikh","doi":"10.4103/ijc.ijc_1111_22","DOIUrl":"10.4103/ijc.ijc_1111_22","url":null,"abstract":"<p><strong>Background: </strong>Consumption of tobacco products including smokeless tobacco is a public health problem. Measures of tobacco control along with promotion of tobacco cessation will have a great impact in reducing the burden tobacco-related diseases. The objectives of current paper were to create cancer awareness and understand predictors influencing use of smokeless tobacco among the public transport bus employees.</p><p><strong>Methods: </strong>Around 4000 public transport bus employees in Mumbai were enrolled after obtaining written informed consent. They were randomized in four arms. Pretest and posttest were conducted to assess their knowledge attitudes and practices regarding tobacco use. Employees were given detailed health education regarding hazards of tobacco and were invited for oral cancer screening. The screen positive participants were referred to the nodal hospital for further management.</p><p><strong>Results: </strong>2118 (52.95%) employees enrolled consumed tobacco in smokeless forms. Only 174 (8.21%) tobacco users used smoking forms. Khaini was the most common form of tobacco used, followed by masheri/gul. The median frequency of use of different tobacco products varied from 2 to 4 per day. The mean age at initiation of tobacco was 25.76 ± 8.46 years. According to the results of the multivariate analysis, married men, above 40 years, bus driver, belonging to Hindu religion, consuming alcohol, and with no family member using tobacco use were at higher risk of being chronic tobacco users.</p><p><strong>Conclusion: </strong>Awareness about hazards of tobacco and stringent laws against use of smokeless tobacco should be implemented to guard the employees from harmful effects of tobacco use.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"395-401"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of high-grade diffuse glioneuronal tumor treated with VMAT radiotherapy. 用VMAT放射治疗罕见的高级别弥漫性胶质神经元肿瘤1例。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_58_23
Sujata Sarkar, Irfan Bashir, Roopesh R Yotham, Ravindra K Saran

Abstract: Glioneuronal tumors are a very rare type of central nervous system (CNS) tumors. Due to rarity, even literature is limited. There is inconsistency in literature with respect to prevalence in different age groups, sex predilection, and treatment. Diagnosis of diffuse glioneuronal tumors is based on both radiologic and histopathologic features. Radiologically, they are often large, ill-defined lesions. On immunohistochemistry, the are positive for glial fibrillary acidic protein (GFAP), OLIG2, S100, and synaptophysin and negative for IDH1. Recently, glioneuronal tumors are included in the 2016 World Health Organization (WHO) classification of CNS neoplasms; however, there are many cases of glioneuronal tumors with distinctive morphologic features that are still not formally included in any classification. Similarly, there is vast disparity between treatments in various literature reports, ranging from surgery to chemoradiation to craniospinal irradiation. Here, we are presenting a case of high-grade diffuse glioneuronal tumor in a 28-year-old male. We have described the radiologic and pathologic features in our case. He was treated with volumetric modulated arc technique (VMAT) radiotherapy and concurrent chemotherapy.

摘要:神经胶质细胞肿瘤是一种非常罕见的中枢神经系统肿瘤。由于稀有性,甚至文学也是有限的。文献中关于不同年龄组、性别偏好和治疗的患病率存在不一致。弥漫性胶质细胞肿瘤的诊断是基于影像学和组织病理学特征。放射学上,它们通常是大的、界限不清的病变。免疫组化结果显示,胶质纤维酸性蛋白(GFAP)、OLIG2、S100和synaptophysin阳性,IDH1阴性。最近,胶质神经细胞肿瘤被列入2016年世界卫生组织(WHO)中枢神经系统肿瘤分类;然而,仍有许多具有独特形态特征的胶质神经元肿瘤病例未被正式纳入任何分类。同样,在各种文献报道中,从手术到放化疗再到颅脊髓照射,治疗方法也存在巨大差异。在此,我们报告一位28岁男性的高级别弥漫性胶质细胞肿瘤。我们已经描述了本病例的放射学和病理学特征。病人接受体积调制弧线技术(VMAT)放疗和同期化疗。
{"title":"A rare case of high-grade diffuse glioneuronal tumor treated with VMAT radiotherapy.","authors":"Sujata Sarkar, Irfan Bashir, Roopesh R Yotham, Ravindra K Saran","doi":"10.4103/ijc.ijc_58_23","DOIUrl":"https://doi.org/10.4103/ijc.ijc_58_23","url":null,"abstract":"<p><strong>Abstract: </strong>Glioneuronal tumors are a very rare type of central nervous system (CNS) tumors. Due to rarity, even literature is limited. There is inconsistency in literature with respect to prevalence in different age groups, sex predilection, and treatment. Diagnosis of diffuse glioneuronal tumors is based on both radiologic and histopathologic features. Radiologically, they are often large, ill-defined lesions. On immunohistochemistry, the are positive for glial fibrillary acidic protein (GFAP), OLIG2, S100, and synaptophysin and negative for IDH1. Recently, glioneuronal tumors are included in the 2016 World Health Organization (WHO) classification of CNS neoplasms; however, there are many cases of glioneuronal tumors with distinctive morphologic features that are still not formally included in any classification. Similarly, there is vast disparity between treatments in various literature reports, ranging from surgery to chemoradiation to craniospinal irradiation. Here, we are presenting a case of high-grade diffuse glioneuronal tumor in a 28-year-old male. We have described the radiologic and pathologic features in our case. He was treated with volumetric modulated arc technique (VMAT) radiotherapy and concurrent chemotherapy.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"428-431"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence-based parotid contouring for radiation oncology in head and neck cancers. 基于人工智能的腮腺轮廓在头颈部肿瘤放射肿瘤学中的应用。
IF 1.1 4区 医学 Q4 ONCOLOGY Pub Date : 2025-07-01 Epub Date: 2025-11-21 DOI: 10.4103/ijc.ijc_473_23
Harshee D Pitroda, Kaustav Talapatra, Manoj Sankhe, G Kiron, Nikhil Bardeskar, Alauddeen R Shaikh, Prashasti Kanikar, Hemit Shah, Jishnu J Nair, Anand Parab, Divya Chhoriya, Rohit Kamath, Vivan Rupani, Deep R Shah, Trisha Sarkar, Deepak Patkar

Background: Radiation therapy plays a critical role in head and neck cancer treatment, which can utilize artificial intelligence algorithms for automatic contour segmentation, treatment planning, and the selection of individual treatments. During the planning phase of radiation therapy, organs at risk (OARs), like the parotid gland, must be identified and mapped out to avoid unwanted side effects. Manual contouring of the parotid gland can be time-consuming and error-prone, causing interobserver variability. This study presents an algorithmic framework for the automated delineation of parotid glands using artificial intelligence and deep learning algorithms that interprets image sets to increase the precision and effectiveness of treatment planning, reduce the risk of side effects, and enhance treatment outcomes. Auto contouring increases the consistency and reproducibility of treatment plans and reduces the need for recontouring.

Methods: In this study, CT scans of 20 anonymized datasets were used. The slices were visualized with their corresponding contours. Further, the CT scans were preprocessed, and various image processing techniques were applied. The dataset generation process was automated, and the data were fed into the developed model. The U-Net architecture was used to create the model. The evaluation metrics used for the model were Accuracy, Precision, Recall, Loss, and Intersection Over Union (IOU).

Results: The proposed model gave a validation accuracy of auto contouring for the left contour to be ~97%. A validation accuracy for the right contour is ~96%.

Conclusions: The auto contouring of parotid glands proves to be a convenient and reliable framework that can be applied and used by radiation oncologists.

背景:放射治疗在头颈癌治疗中起着至关重要的作用,它可以利用人工智能算法进行自动轮廓分割、治疗计划和个体治疗选择。在放射治疗的计划阶段,必须确定危险器官(OARs),如腮腺,以避免不必要的副作用。手动轮廓腮腺可能是耗时和容易出错,造成观察者之间的差异。本研究提出了一种利用人工智能和深度学习算法对腮腺进行自动描述的算法框架,该算法可以解释图像集,以提高治疗计划的准确性和有效性,降低副作用的风险,并提高治疗效果。自动轮廓增加了治疗计划的一致性和可重复性,并减少了重新轮廓的需要。方法:本研究使用了20个匿名数据集的CT扫描。这些切片及其相应的轮廓被可视化。此外,对CT扫描进行预处理,并应用各种图像处理技术。数据集生成过程是自动化的,数据被输入到所开发的模型中。使用U-Net体系结构创建模型。用于模型的评估指标是准确性、精密度、召回率、损失和交叉联合(IOU)。结果:该模型对左侧轮廓的自动轮廓的验证精度为97%。对正确轮廓线的验证精度约为96%。结论:腮腺自动轮廓是一种方便、可靠的框架,可为放射肿瘤学家应用。
{"title":"Artificial intelligence-based parotid contouring for radiation oncology in head and neck cancers.","authors":"Harshee D Pitroda, Kaustav Talapatra, Manoj Sankhe, G Kiron, Nikhil Bardeskar, Alauddeen R Shaikh, Prashasti Kanikar, Hemit Shah, Jishnu J Nair, Anand Parab, Divya Chhoriya, Rohit Kamath, Vivan Rupani, Deep R Shah, Trisha Sarkar, Deepak Patkar","doi":"10.4103/ijc.ijc_473_23","DOIUrl":"https://doi.org/10.4103/ijc.ijc_473_23","url":null,"abstract":"<p><strong>Background: </strong>Radiation therapy plays a critical role in head and neck cancer treatment, which can utilize artificial intelligence algorithms for automatic contour segmentation, treatment planning, and the selection of individual treatments. During the planning phase of radiation therapy, organs at risk (OARs), like the parotid gland, must be identified and mapped out to avoid unwanted side effects. Manual contouring of the parotid gland can be time-consuming and error-prone, causing interobserver variability. This study presents an algorithmic framework for the automated delineation of parotid glands using artificial intelligence and deep learning algorithms that interprets image sets to increase the precision and effectiveness of treatment planning, reduce the risk of side effects, and enhance treatment outcomes. Auto contouring increases the consistency and reproducibility of treatment plans and reduces the need for recontouring.</p><p><strong>Methods: </strong>In this study, CT scans of 20 anonymized datasets were used. The slices were visualized with their corresponding contours. Further, the CT scans were preprocessed, and various image processing techniques were applied. The dataset generation process was automated, and the data were fed into the developed model. The U-Net architecture was used to create the model. The evaluation metrics used for the model were Accuracy, Precision, Recall, Loss, and Intersection Over Union (IOU).</p><p><strong>Results: </strong>The proposed model gave a validation accuracy of auto contouring for the left contour to be ~97%. A validation accuracy for the right contour is ~96%.</p><p><strong>Conclusions: </strong>The auto contouring of parotid glands proves to be a convenient and reliable framework that can be applied and used by radiation oncologists.</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"62 3","pages":"355-364"},"PeriodicalIF":1.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian journal of cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1